Mental illness and warfarin use in atrial fibrillation

American Journal of Managed Care

Volumn 17, Issue 9, 2011, Pages 617-624

  Walker, Graham A ^a,b   Heidenreich, Paul A ^a,b   Phibbs, Ciaran S ^a,b   Go, Alan S ^a,c,d   Chiu, Victor Y ^a   Schmitt, Susan K ^a   Ananth, Lakshmi ^a   Frayne, Susan M ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; TREATMENT RESPONSE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; DRUG INTERACTIONS; DRUG MONITORING; HEALTH STATUS INDICATORS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MENTAL DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; WARFARIN;

EID: 80053076282     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19. (Pubitemid 24028993)
2. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338(21):1516-1520. (Pubitemid 28226280)
3. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000;283(4):506-511. (Pubitemid 30062867)
4. Graber MA, Bergus G, Dawson JD, Wood GB, Levy BT, Levin I. Effect of a patient's psychiatric history on physicians' estimation of probability of disease. J Gen Intern Med. 2000;15(3):204-206. (Pubitemid 30155355)
5. Petersen L, Normand S, Druss B, Rosenheck R. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res. 2003;38(1, pt 1):41-63. (Pubitemid 36373298)
6. Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the Veterans Health Administration. Am J Psychiatry. 2002;159(9):1584-1590. (Pubitemid 35006741)
7. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165(22):2631-2638. (Pubitemid 41785061)
8. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155(5):469-473.
9. Hill JD, Mottram EM, Killeen PD. Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age. J R Coll Gen Pract. 1987;37(297):172-173.
10. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [published correction appears in Arch Intern Med. 1994;154(19):2254]. Arch Intern Med. 1994;154(13):1449-1457.
11. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
12. Fuster V, Rydén LE, Cannom DS, et al; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-e354.
13. Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011;8(1):157-176.
14. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996;27(3):305-308. (Pubitemid 26085005)
15. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105(2):91-99. (Pubitemid 28405230)
16. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis. 2000;9(3):283-292. (Pubitemid 30201262)
17. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-2870. (Pubitemid 32537350)
18. Selim AJ, Fincke G, Ren XS, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004;27(3):281-295. (Pubitemid 38780398)
19. Selim A, Fincke G, Ren X, et al. The Comorbidity Index. In: Goldfield N, Pine M, Pine J, eds. Measuring and Managing Health Care Quality. New York: Aspen; 2002.
20. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019-1026. (Pubitemid 37087616)
21. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119(1)(suppl): 108S-121S.
22. Druss BG, Rosenheck RA, Desai MM, Perlin JB. Quality of preventive medical care for patients with mental disorders. Med Care. 2002;40(2):129-136.
23. de Groot M, Jacobson AM, Samson JA, Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res. 1999;46(5):425-435. (Pubitemid 29277214)
24. Braddock CH 3rd, Fihn SD, Levinson W, Jonsen AR, Pearlman RA. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting. J Gen Intern Med. 1997;12(6):339-345.
25. Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159(10):1069- 1075. (Pubitemid 29230858)
26. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153(16):1869-1878. (Pubitemid 23329841)
27. van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care. 2002;40(1)(suppl):140-151.
28. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ. 2006;332(7534):141-145.
29. Hollowell J, Ingelgard A, Reddy P, Gold K, Fitzmaurice D. Patient preference and capabilities are at least as important as clinical contraindications as barriers to prescribing warfarin in patients with atrial fibrillation [abstract 2204]. Blood. 2004;104(11, pt 1):606a.
30. Birdwell BG, Herbers JE, Kroenke K. Evaluating chest pain: the patient's presentation style alters the physician's diagnostic approach. Arch Intern Med. 1993;153(17):1991-1995. (Pubitemid 23263560)
31. Sansone RA, Sansone LA. Warfarin and antidepressants: happiness without hemorrhaging. Psychiatry (Edgmont). 2009;6(7):24-29.
32. Schauer DP, Moomaw CJ, Wess M, Webb T, Eckman MH. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med. 2005;20(12):1114-1119. (Pubitemid 43110261)
33. Freeman JV, Zhu RP, Owens DK, et al. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011;154(1):1-11.
34. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278-3285.
35. Weisbord SD, Whittle J, Brooks RC. Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med. 2001;16(11):743-749. (Pubitemid 34209061)